Home / Research & Technology / Publications / CD34+ cell therapy for no option refractory disabling angina: Time for FDA approval? CD34+ cell therapy for no option refractory disabling angina: Time for FDA approval? Lillian Benck, Timothy D. Henry, Carrev (2019), Learn More
